264 related articles for article (PubMed ID: 32224374)
1. Stepwise-activatable hypoxia triggered nanocarrier-based photodynamic therapy for effective synergistic bioreductive chemotherapy.
Ihsanullah KM; Kumar BN; Zhao Y; Muhammad H; Liu Y; Wang L; Liu H; Jiang W
Biomaterials; 2020 Jul; 245():119982. PubMed ID: 32224374
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia and Singlet Oxygen Dual-Responsive Micelles for Photodynamic and Chemotherapy Therapy Featured with Enhanced Cellular Uptake and Triggered Cargo Delivery.
Guo X; Han L; Chen W; He H; Zhang W; Huang C; Wang X
Int J Nanomedicine; 2024; 19():247-261. PubMed ID: 38229704
[TBL] [Abstract][Full Text] [Related]
3. Cancer-Selective Bioreductive Chemotherapy Mediated by Dual Hypoxia-Responsive Nanomedicine upon Photodynamic Therapy-Induced Hypoxia Aggravation.
Zhu R; He H; Liu Y; Cao D; Yan J; Duan S; Chen Y; Yin L
Biomacromolecules; 2019 Jul; 20(7):2649-2656. PubMed ID: 31125209
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia Induced by Upconversion-Based Photodynamic Therapy: Towards Highly Effective Synergistic Bioreductive Therapy in Tumors.
Liu Y; Liu Y; Bu W; Cheng C; Zuo C; Xiao Q; Sun Y; Ni D; Zhang C; Liu J; Shi J
Angew Chem Int Ed Engl; 2015 Jul; 54(28):8105-9. PubMed ID: 26012928
[TBL] [Abstract][Full Text] [Related]
5. Dissolving Microneedle-Based Cascade-Activation Nanoplatform for Enhanced Photodynamic Therapy of Skin Cancer.
Ma J; Tai Z; Li Y; Li Y; Wang J; Zhou T; Shen M; Xin R; Shen C; Zhu Q; Chen Z
Int J Nanomedicine; 2024; 19():2057-2070. PubMed ID: 38482522
[TBL] [Abstract][Full Text] [Related]
6. Light-Enhanced Hypoxia-Response of Conjugated Polymer Nanocarrier for Successive Synergistic Photodynamic and Chemo-Therapy.
Zhang X; Wu M; Li J; Lan S; Zeng Y; Liu X; Liu J
ACS Appl Mater Interfaces; 2018 Jul; 10(26):21909-21919. PubMed ID: 29882654
[TBL] [Abstract][Full Text] [Related]
7. Targeting triple-negative breast cancer with an aptamer-functionalized nanoformulation: a synergistic treatment that combines photodynamic and bioreductive therapies.
Chou YT; Lin CY; Wen JW; Hung LC; Chang YF; Yang CM; Wu LC; Ho JA
J Nanobiotechnology; 2021 Mar; 19(1):89. PubMed ID: 33781277
[TBL] [Abstract][Full Text] [Related]
8. ROS-sensitive biomimetic nanocarriers modulate tumor hypoxia for synergistic photodynamic chemotherapy.
Liu H; Jiang W; Wang Q; Hang L; Wang Y; Wang Y
Biomater Sci; 2019 Aug; 7(9):3706-3716. PubMed ID: 31187794
[TBL] [Abstract][Full Text] [Related]
9. A photothermal-hypoxia sequentially activatable phase-change nanoagent for mitochondria-targeting tumor synergistic therapy.
Qu J; Teng D; Sui G; Guan S; Wang Y; Wang Q; Lin Y; Ran H; Wang Z; Wang H
Biomater Sci; 2020 Jun; 8(11):3116-3129. PubMed ID: 32352102
[TBL] [Abstract][Full Text] [Related]
10. A light and hypoxia-activated nanodrug for cascade photodynamic-chemo cancer therapy.
Zhong Y; Huang S; Zheng C; Huang J; Li B; Han S; Xiao H; Wang Y; Shuai X
Biomater Sci; 2021 Jul; 9(15):5218-5226. PubMed ID: 34169939
[TBL] [Abstract][Full Text] [Related]
11. Enzyme/GSH dual-responsive biodegradable nanohybrid for spatiotemporally specific photodynamic and hypoxia-augmented therapy against tumors.
Cheng D; Ji Y; Wang B; Jin T; Xu Y; Qian X; Zhu W
Int J Pharm; 2021 Jun; 603():120730. PubMed ID: 34029662
[TBL] [Abstract][Full Text] [Related]
12. Tumor acidity/redox hierarchical-activable nanoparticles for precise combination of X-ray-induced photodynamic therapy and hypoxia-activated chemotherapy.
Zhang B; Xue R; Lyu J; Gao A; Sun C
J Mater Chem B; 2022 May; 10(20):3849-3860. PubMed ID: 35470367
[TBL] [Abstract][Full Text] [Related]
13. A hybrid metal-organic framework nanomedicine-mediated photodynamic therapy and hypoxia-activated cancer chemotherapy.
Jia Z; Gao Y; Ni J; Wu X; Mao Z; Sheng G; Zhu Y
J Colloid Interface Sci; 2023 Jan; 629(Pt B):379-390. PubMed ID: 36162395
[TBL] [Abstract][Full Text] [Related]
14. Anti-LDLR modified TPZ@Ce6-PEG complexes for tumor hypoxia-targeting chemo-/radio-/photodynamic/photothermal therapy.
Song C; Xu W; Wei Z; Ou C; Wu J; Tong J; Cai Y; Dong X; Han W
J Mater Chem B; 2020 Jan; 8(4):648-654. PubMed ID: 31898718
[TBL] [Abstract][Full Text] [Related]
15. Application of tumor pH/hypoxia-responsive nanoparticles for combined photodynamic therapy and hypoxia-activated chemotherapy.
Zhang Z; Feng J; Zhang T; Gao A; Sun C
Front Bioeng Biotechnol; 2023; 11():1197404. PubMed ID: 37362218
[No Abstract] [Full Text] [Related]
16. Controllable hypoxia-activated chemotherapy as a dual enhancer for synergistic cancer photodynamic immunotherapy.
Wang M; He M; Zhang M; Xue S; Xu T; Zhao Y; Li D; Zhi F; Ding D
Biomaterials; 2023 Oct; 301():122257. PubMed ID: 37531778
[TBL] [Abstract][Full Text] [Related]
17. Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy.
Wang Y; Xie Y; Li J; Peng ZH; Sheinin Y; Zhou J; Oupický D
ACS Nano; 2017 Feb; 11(2):2227-2238. PubMed ID: 28165223
[TBL] [Abstract][Full Text] [Related]
18. Carbon monoxide (CO)-Strengthened cooperative bioreductive anti-tumor therapy via mitochondrial exhaustion and hypoxia induction.
Li Y; Dang J; Liang Q; Yin L
Biomaterials; 2019 Jul; 209():138-151. PubMed ID: 31034982
[TBL] [Abstract][Full Text] [Related]
19. Oxygen-producing catalase-based prodrug nanoparticles overcoming resistance in hypoxia-mediated chemo-photodynamic therapy.
Cheng X; He L; Xu J; Fang Q; Yang L; Xue Y; Wang X; Tang R
Acta Biomater; 2020 Aug; 112():234-249. PubMed ID: 32502633
[TBL] [Abstract][Full Text] [Related]
20. Iodinated cyanine dye-based nanosystem for synergistic phototherapy and hypoxia-activated bioreductive therapy.
Dong Y; Zhou L; Shen Z; Ma Q; Zhao Y; Sun Y; Cao J
Drug Deliv; 2022 Dec; 29(1):238-253. PubMed ID: 35001784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
